Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
185 participants
OBSERVATIONAL
2010-04-15
2020-07-10
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Non-invasive Test-guided Tailored Therapy Versus Empiric Treatment for Helicobacter Pylori Infection.
NCT04107194
Genotypic Resistance-guided Versus Empirical Therapy for H. Pylori Eradication.
NCT04090021
Helicobacter Pylori First-line Treatment Containing Tetracycline in Patients Allergic to Penicillin
NCT05129176
Molecular Detection of Antibiotic Resistance and H Pylori Eradication
NCT01168063
A Unique Regimen for Treatment of Helicobacter Pylori Infection
NCT03491995
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
OTHER
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Helicobacter pylori resistance
Patients with treatment resistance to Helicobacter pylori treatment registered at GI-unites from 1990-2012 and included from 2010 to 2012. These patients were treated with a triple therapy of levofloxacin, amoxicillin and proton inhibitor for 10 days
levofloxacin, amoxicillin, clarithromycin
Triple therapy of Helicobacter pylori including two antibiotics and a proton inhibitor for 10 days
Newly diagnosed Helicobacter pylori
Patients with newly diagnosed Helicobacter pylori infection from 2010-2012.These patients were treated with a triple therapy of clarithromycin, amoxicillin and proton inhibitor for 10 days
levofloxacin, amoxicillin, clarithromycin
Triple therapy of Helicobacter pylori including two antibiotics and a proton inhibitor for 10 days
Previously eradicated Helicobacter pylori infection
Patients with previously Helicobacter pylori infection included from 2010-2012.
No interventions assigned to this group
Never Helicobacter pylori infection
Patients with previously Helicobacter pylori infection included from 2010-2012.
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
levofloxacin, amoxicillin, clarithromycin
Triple therapy of Helicobacter pylori including two antibiotics and a proton inhibitor for 10 days
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
18 Years
75 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University Hospital of North Norway
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Jon Florholmen
professor, MD
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Jon Florholmen
Role: PRINCIPAL_INVESTIGATOR
Department of Gastroenterology, Norwegian Artic University/Universiuty of Tromsø, Norway
References
Explore related publications, articles, or registry entries linked to this study.
Nestegard O, Moayeri B, Halvorsen FA, Tonnesen T, Sorbye SW, Paulssen E, Johnsen KM, Goll R, Florholmen JR, Melby KK. Helicobacter pylori resistance to antibiotics before and after treatment: Incidence of eradication failure. PLoS One. 2022 Apr 20;17(4):e0265322. doi: 10.1371/journal.pone.0265322. eCollection 2022.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
University Hosp North Norway
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.